ICA69 Antibodies

Santa Cruz Biotechnology features a diverse variety of ICA69 monoclonal antibodies for advanced research in neuroscience and cellular signaling. ICA69 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ICA69, or Islet Cell Autoantigen 69, plays a crucial role in regulating insulin secretion and is implicated in the pathogenesis of autoimmune diabetes. ICA69's function in synaptic transmission and neuroendocrine signaling makes it significant for both metabolic and neurological research. Understanding ICA69 can provide insights into various diseases, including type 1 diabetes and neurodegenerative disorders. Researchers worldwide rely on ICA69 monoclonal antibodies to advance their studies in cellular biology and disease mechanisms. ICA69 monoclonal antibodies enable detailed investigation of protein expression patterns and interactions in various experimental models. The high specificity and reliability of Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful contributions to scientific knowledge and therapeutic development.